San Diego, Calif., January 5, 2016 – Forge Therapeutics, Inc., a biotechnology company discovering innovative therapeutics using a breakthrough drug discovery platform targeting metalloproteins, announced today that Zachary Zimmerman, Ph.D., Chief Executive Officer, will be presenting at the Biotech Showcase 2016 Conference being held at the Parc 55 Union Square, San Francisco, CA.

Details of Forge’s presentation are as follows:

Event:             Biotech Showcase 2016 Conference

Date:              Tuesday, January 12th

Time:              2:15 PM PST

Track:             E – Davidson (4th Floor)

The presentation will include an overview of Forge’s novel chemistry platform, lead therapeutic programs, as well as financing and partnering strategies.

About Forge Therapeutics, Inc.

Forge Therapeutics, Inc. (“Forge”) is a biotechnology start-up that leverages its novel chemistry platform to develop small molecule inhibitors to target metalloproteins.  Metalloproteins are proteins that require metal ions for their biological function and make up over 1/3 of the proteins in the human body.  Forge uses a proprietary approach comprised of molecular modeling for rational drug design along with fundamental knowledge and expertise in bioinorganic chemistry to target metalloproteins. The name Forge Therapeutics comes from two definitions for forge: to manipulate (inhibit) a metal object (metalloprotein) and to move forward steadily with a purpose (the Forge team).  Forge Therapeutics, Inc., maintains its headquarters in San Diego, California.  To learn more please visit www.ForgeTherapeutics.com

About Biotech Showcase 2016

Biotech Showcase™ is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and potential strategics in one place during the course of one of the industry’s largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco during this critical week which is widely viewed as setting the tone for the coming year.

Contact:

Info@ForgeTherapeutics.com